Many accumulating pieces of evidence indicated that SOCS had low expression in various tumors, including lung cancer, gastric cancer, hepatocellular carcinoma, prostate cancer, multiple myeloma, pancreatic cancer, leukemia and lymphoma (18–20). The gene discussed is CISH; the disease is prostate cancer.